Supplemental material
Journal of Asthma
Volume 59, 2022 - Issue 11
Open access
3,675
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy
Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan
Yuji Tohda,a Kindai University Hospital, Osakasayama, Osaka, JapanView further author information
, MD, PhD, Hisako Matsumoto,b Department of Respiratory Medicine & Allergology, Kindai University Faculty of Medicine, Osakasayama, Osaka, JapanView further author information
, MD, PhD, Masanori Miyata,c Immunology Medical, Sanofi K.K, Tokyo, JapanView further author information
, PhD, Yurie Taguchi,d Health Economics and Value Assessment, Market Access, Sanofi K.K, Tokyo, JapanView further author information
, PhD, MBA, Maki Ueyama,e Health Economics and Outcomes Research, Creativ-Ceutical, Tokyo, JapanView further author information
, PhD, MPA, Florence Joulain,f Global Health Economics and Value Assessment, Sanofi, Chilly-Mazarin, FranceView further author information
, MSc & Ichiro Arakawa,g Office of Human Research Studies, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, JapanCorrespondence[email protected]
View further author information
, PhD show allView further author information
Pages 2162-2173
|
Received 18 Mar 2021, Accepted 17 Oct 2021, Published online: 08 Dec 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.